SEC Filing - bluebird bio, Inc.
bluebird bio to Present at the 31st Annual Credit Suisse Healthcare Conference | Business Wire
Articles with bluebird bio
bluebird bio Announces EU Conditional Marketing Authorization for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype
bluebird bio Dedicates New Biomanufacturing Plant in Durham | North Carolina Biotechnology Center
Roche's Spark Therapeutics, bluebird resolve suit on sickle cell disease 'Spark' campaign | Seeking Alpha
Bluebird Bio and Resilience Announce Strategic Alliance | citybiz
bluebird bio Launches Gene Therapy for Severe Blood Disorder in Germany | North Carolina Biotechnology Center
bluebird bio provides update on 2seventy bio spin-off - PMLiVE
Untitled
Our Leadership Team | bluebird bio
bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies - Pharmaceutical Technology
In the Boardroom
Contact Us | bluebird bio
Our Leadership Team | bluebird bio
Two positive AdCom votes for bluebird bio encouraging for gene therapies
bluebird bio Office Photos | Glassdoor
SEC Filing - bluebird bio, Inc.
Working at bluebird bio | Glassdoor
blue-ex991_25.htm
Our Leadership Team | bluebird bio
With the pricing situation 'untenable' in Europe, bluebird will wind down its operations in the 'broken' market
bluebird bio - YouTube
Gene Therapy Could See Revival With Bluebird Drugs at FDA Panel - Bloomberg
bluebird bio Office Photos | Glassdoor
Bluebird Bio $BLUE : r/HellsTradingFloor
Stephen Dicker - Senior Director - bluebird bio | LinkedIn
